S
SillaJen Inc
KOSDAQ:215600
SillaJen Inc
KOSDAQ:215600
Price:
4 000
KRW
Market Closed
Market Cap:
₩552.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
SillaJen Inc
KOSDAQ:215600
|
KR |
|
Notable Labs Ltd
NASDAQ:NTBL
|
IL |
|
Cavotec SA
STO:CCC
|
CH |
|
Titomic Ltd
ASX:TTT
|
AU |
|
Limitless Earth PLC
LSE:LME
|
UK |
|
S
|
Sato Foods Industries Co Ltd
TSE:2814
|
JP |
|
F
|
FUREN Group Pharmaceutical Co Ltd
SSE:600781
|
CN |
|
C
|
Cuscapi Berhad
KLSE:CUSCAPI
|
MY |
|
Amte Power PLC
LSE:AMTE
|
UK |
|
T
|
TeamViewer SE
XBER:TMV
|
DE |
|
Anatolia Tani ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi ve Ticaret AS
IST:ANGEN.E
|
TR |
|
A
|
AECI Ltd
JSE:AFE
|
ZA |
Multiples-Based Value
The Multiples-Based Value of one SillaJen Inc stock under the Base Case scenario is hidden KRW. Compared to the current market price of 4 000 KRW, SillaJen Inc is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SillaJen Inc Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
SillaJen Inc Competitors
SillaJen Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
S
|
SillaJen Inc
KOSDAQ:215600
|
552.2B KRW | 70.4 | -23.8 | -19.6 | -18.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD | 6.2 | 90 | 14.9 | 20.7 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD | 109.7 | -1 712.3 | 15 906.4 | -1 796.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.1B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD | 5.8 | 19.9 | 12.4 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD | 9.4 | 28.5 | 21.4 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD | 3.1 | 34.4 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
